RSS Feed
February 1st, 2012 
FAKE NEWS for the Zionist agenda WEDNESDAY, Feb. 1 (HealthDay News) — The American Academy of
Pediatrics is recommending that all boys between the ages of 11 and 12
receive the three-dose vaccine for the human papillomavirus (HPV).
That’s the most significant change in the latest immunization
schedules, released Wednesday by the pediatrics group. The HPV vaccine has
been available and recommended for girls and young women since 2006,
because it was believed that the vaccine would be most effective at
preventing cervical cancer. Since then, other cancers thought to be caused
by HPV have been on the increase, including anal cancer and some head and
neck cancers.
“Initially, when HPV vaccines were being evaluated, there was an
assumption that they would be for preventing cervical cancer and genital
warts. Subsequent to that, some things have occurred that show us that
providing the vaccine to both genders would be beneficial,” said Dr.
Michael T. Brady, chairman of the AAP’s Committee on Infectious Diseases
and chairman of the department of pediatrics at Nationwide Children’s
Hospital in Columbus, Ohio.
“Currently, our approach isn’t effective from a public health
perspective since males are also participants in the transmission of HPV,”
he said. “If we include both girls and boys, we could have a potential
impact on HPV transmission.”
The new guidelines mirror a recommendation released last October by the
U.S. Centers for Disease Control and Prevention’s Advisory Committee on
Immunization Practices (ACIP).
The HPV virus can cause cervical, anal and some head and neck cancers,
as well as genital warts, according to the CDC. The virus is transmitted
though genital or oral sex, and many people who have the virus don’t know
they have it. To be effective, the vaccine for the virus must be given
before someone is ever infected. That’s why health experts recommend that
the vaccine be given in the pre-teen years of 11 or 12.
“I understand most parents aren’t interested in hearing about their
children being sexually active, but this is a cancer vaccine that’s given
for a number of different reasons that has to be given prior to the onset
of sexual activity,” Brady said, adding that another reason to give the
vaccine at a younger age is that studies have shown the immune system
responds more strongly to the vaccine at this age. “Children between 9 and
12 get the best response to this vaccine,” he explained.
He also cautioned that this vaccine doesn’t protect against all
sexually transmitted diseases. Whether vaccinated against HPV or not,
practicing safe sex is still crucial for preventing potentially
life-threatening infections.
“Plus, if you give HPV vaccine only to females, you won’t have any
impact for men who have sex with men. By expanding the vaccine to both
genders, we would reduce the overall transmission of HPV. And, we would
make sure all of the complications of HPV would be prevented in both
genders,” said Brady.
Brady noted that this vaccine is quite safe, with the most significant
side effect being transient soreness in the vaccinated arm. “This vaccine
has very minimal risk,” he said. However, he said any time you give
children in this age group a vaccination or take blood from them, it’s
likely that they will faint more often than people in other age groups.
For this reason, your child will be asked to sit for 15 minutes or so
after getting the vaccine to make sure that doesn’t happen.
One expert agreed with the new guideline.
“What the AAP is doing is being consistent with the ACIP
recommendations. There will be a benefit to women from immunizing men, as
well as the prevention of warts in males, and possibly cancer associated
with HPV,” said Dr. Kenneth Bromberg, director of the Vaccine Research
Center at the Brooklyn Hospital Center in New York City.
Both experts thought that by providing the vaccine to both girls and
boys, the vaccine might become less controversial. And, because the ACIP
recommended it, both said that insurance coverage likely wouldn’t be an
issue.
The other noteworthy changes to the AAP schedule included adding a
meningococcal booster shot (against meningitis) at age 16. Brady said the
initial vaccine is given around 11 or 12 years, and it was initially
thought that it would last 10 years. Now, scientists know that immunity
begins to wane after five years. Teens and young adults are most at risk
for infectious meningitis when they’re living in communal situations, such
as college dormitories.
The AAP is also recommending that children between the ages of 6 months
and 8 years who didn’t receive a flu vaccine for the 2010-11 season should
receive two doses of flu vaccine this year.
The new AAP recommendations are published in the February issue of
Pediatrics.
More information
Learn more about HPV vaccine from the U.S. Centers for
Disease Control and Prevention.
Views: 0
Posted in 
Tags: 
